(Q41521283)

2 October 2017

1 reference

title

Fosinopril. A review of its pharmacology and clinical efficacy in the management of heart failure (English)

1 reference

2 October 2017

Davis R

1

1 reference

2 October 2017

Coukell A

series ordinal

2

1 reference

2 October 2017

McTavish D

series ordinal

3

1 reference

2 October 2017

publication date

1 July 1997

1 reference

2 October 2017

1 reference

2 October 2017

volume

54

1 reference

2 October 2017

issue

1

1 reference

2 October 2017

page(s)

103-116

1 reference

Fosinopril: a reappraisal of its pharmacology and therapeutic efficacy in essential hypertension

2 October 2017

cites work

1 reference

12 December 2020

Guidelines for the diagnosis of heart failure. The Task Force on Heart Failure of the European Society of Cardiology

1 reference

12 December 2020

Single-dose and steady-state pharmacokinetics of fosinopril and fosinoprilat in patients with hepatic impairment

1 reference

12 December 2020

The epidemiology of heart failure: the Framingham Study

1 reference

12 December 2020

A new approach to the analysis of clinical drug trials with withdrawals.

1 reference

12 December 2020

Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor

1 reference

12 December 2020

ASHP therapeutic guidelines on angiotensin-converting-enzyme inhibitors in patients with left ventricular dysfunction. This official ASHP practice standard was developed through the ASHP Commission on Therapeutics and approved by the ASHP Board of D

1 reference

12 December 2020

Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure. Fosinopril Efficacy/Safety Trial (FEST) Study Group

1 reference

12 December 2020

Reduction in left ventricular mass in patients with systemic hypertension treated with enalapril, lisinopril, or fosenopril

1 reference

12 December 2020

Plasma endothelin in congestive heart failure: effect of the ACE inhibitor, fosinopril

1 reference

12 December 2020

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

12 December 2020

A Comparison of the Cough Profile of Fosinopril and Enalapril in Hypertensive Patients with a History of ACE Inhibitor-Associated Cough

1 reference

12 December 2020

Fosinopril: pharmacokinetics and pharmacodynamics in congestive heart failure

1 reference

12 December 2020

Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency

1 reference

12 December 2020

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

12 December 2020

Disposition of fosinopril sodium in healthy subjects

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors in left ventricular dysfunction

1 reference

12 December 2020

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

12 December 2020

Comparative effects of fosinopril and nifedipine on regression of left ventricular hypertrophy in hypertensive patients: a double-blind study

1 reference

12 December 2020

Effects of fosinopril on exercise tolerance and clinical deterioration in patients with chronic congestive heart failure not taking digitalis. Fosinopril Heart Failure Study Group

1 reference

12 December 2020

Pharmacokinetics of fosinopril in patients with various degrees of renal function

1 reference

12 December 2020

Treatment of heart failure

1 reference

12 December 2020

Current guidelines for the treatment of congestive heart failure

1 reference

12 December 2020

Fosinopril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in essential hypertension

1 reference

12 December 2020

Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure)

1 reference

12 December 2020

Albuminuria and transferrinuria in essential hypertension. Effects of antihypertensive therapy

1 reference

12 December 2020

ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study

1 reference

12 December 2020

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

12 December 2020

The pharmacokinetics and pharmacodynamics of fosinopril in haemodialysis patients

1 reference

12 December 2020

Adverse effects of the angiotensin-converting enzyme inhibitors

1 reference

12 December 2020

The clinical pharmacology of angiotensin converting enzyme inhibitors in chronic heart failure.

1 reference

12 December 2020

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

12 December 2020

Fosinopril pharmacokinetics and pharmacodynamics in chronic ambulatory peritoneal dialysis patients

1 reference

12 December 2020

Comparison of the Steady-State Pharmacokinetics of Fosinopril, Lisinopril and Enalapril in Patients with Chronic Renal Insufficiency

1 reference

12 December 2020

Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?

1 reference

12 December 2020

10.2165/00003495-199754010-00012

Identifiers

DOI

1 reference

Dimensions Publication ID

2 October 2017

1000682307

0 references

Fatcat ID

release_bnc5j2vasbgupeluc3ioo6q7wu

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bnc5j2vasbgupeluc3ioo6q7wu

24 November 2022

mapped directly with Wikidata item

1 reference